Variant report
Variant | nsv398353 |
---|---|
Chromosome Location | chr8:49021820-49023463 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558706816 | chr8:49021824-49021825 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113111325 | chr8:49021877-49021878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191897665 | chr8:49021991-49021992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113456756 | chr8:49022008-49022009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556438215 | chr8:49022074-49022075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11988128 | chr8:49022082-49022083 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs148088109 | chr8:49022084-49022085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141191651 | chr8:49022151-49022152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376269322 | chr8:49022175-49022176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567450167 | chr8:49022203-49022204 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141890314 | chr8:49022229-49022230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184084796 | chr8:49022244-49022245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146103478 | chr8:49022246-49022247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540301684 | chr8:49022267-49022268 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564768451 | chr8:49022314-49022315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs532130253 | chr8:49022364-49022365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188572800 | chr8:49022457-49022458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562730490 | chr8:49022476-49022477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79127124 | chr8:49022520-49022521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529928814 | chr8:49022566-49022567 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs180929504 | chr8:49022567-49022568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140121154 | chr8:49022574-49022575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185924405 | chr8:49022576-49022577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142174924 | chr8:49022661-49022662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146370177 | chr8:49022780-49022781 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537802665 | chr8:49022809-49022810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541941151 | chr8:49022851-49022852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs80170517 | chr8:49022852-49022853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190394934 | chr8:49022908-49022909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568381365 | chr8:49022918-49022919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556269287 | chr8:49022919-49022920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535674847 | chr8:49022949-49022950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554099858 | chr8:49022985-49022986 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576348067 | chr8:49023061-49023062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs376960413 | chr8:49023062-49023063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572585479 | chr8:49023116-49023117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7828917 | chr8:49023162-49023163 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs558575101 | chr8:49023165-49023166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6986362 | chr8:49023180-49023181 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs71527689 | chr8:49023240-49023241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575746858 | chr8:49023255-49023256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs77851372 | chr8:49023268-49023269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562790939 | chr8:49023299-49023300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530042085 | chr8:49023360-49023361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs139390953 | chr8:49023404-49023405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560126897 | chr8:49023463-49023464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
22q11 deletion syndrome | 20357662 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Gastric cancer | 22014070 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:49018000-49022600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr8:49021400-49035800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr8:49021800-49022400 | Enhancers | HSMM | muscle |
4 | chr8:49021800-49022600 | Enhancers | NH-A | brain |
5 | chr8:49022000-49022400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr8:49022000-49022400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr8:49022000-49022400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr8:49022000-49022400 | Enhancers | Hela-S3 | cervix |
9 | chr8:49022000-49022400 | Enhancers | HMEC | breast |
10 | chr8:49022000-49022400 | Enhancers | HSMMtube | muscle |
11 | chr8:49022000-49022400 | Enhancers | NHEK | skin |
12 | chr8:49022000-49022400 | Enhancers | Osteobl | bone |
13 | chr8:49022000-49023000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr8:49022000-49023000 | Enhancers | Muscle Satellite Cultured Cells | -- |
15 | chr8:49022200-49022400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr8:49022200-49022600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr8:49022400-49022600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr8:49022400-49022800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
19 | chr8:49022600-49022800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr8:49022600-49023200 | Weak transcription | NH-A | brain |
21 | chr8:49023200-49023400 | Enhancers | NH-A | brain |